HomeZ1TS34 • BVMF
add
Zoetis Inc Bdr
Previous close
R$68.00
Day range
R$68.00 - R$69.02
Year range
R$47.10 - R$69.02
Market cap
87.57B USD
Avg Volume
1.15K
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 2.36B | 8.30% |
Operating expense | 787.00M | 6.50% |
Net income | 624.00M | -7.00% |
Net profit margin | 26.43 | -14.13% |
Earnings per share | 1.56 | 10.64% |
EBITDA | 1.03B | 8.17% |
Effective tax rate | 20.00% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.57B | -8.33% |
Total assets | 14.16B | 3.03% |
Total liabilities | 9.20B | 0.84% |
Total equity | 4.96B | — |
Shares outstanding | 453.05M | — |
Price to book | 6.22 | — |
Return on assets | 15.89% | — |
Return on capital | 19.21% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | 624.00M | -7.00% |
Cash from operations | 502.00M | 174.32% |
Cash from investing | -132.00M | -65.00% |
Cash from financing | -763.00M | -54.45% |
Net change in cash | -401.00M | -2.30% |
Free cash flow | 211.38M | 3,422.92% |
About
Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index. Wikipedia
Founded
1952
Headquarters
Website
Employees
14,100